2BBBullish & Bearish
Precigen, Inc. (PGEN) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 37 out of 100.
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari. Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells.
Precigen, Inc.’s current 2BB score is 37 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 72 | Strong |
| Quality | 100 | Very Strong |
| Risk | 24 | Low |
| CEO | Helen Sabzevari |
| Founded | May 21, 1998 |
| Employees | 160 |
| 52-week range | $1.45 – $6.04 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-11 | — | 0.0612 | — | $70.59M |
| 2026-08-04 | — | -0.0136 | — | $28.39M |
| 2026-05-12 | — | -0.0765 | — | $24.48M |
| 2026-03-25 | — | -0.085 | — | $8.45M |